Inventor · disambiguated record
Qingjian Wang
Also filed as: WANG QINGJIAN
8 granted patents·23 pending applications·107 citations·filing 2002–2022
88Inventor score
Top patents by PatentIndex Score
31 records- 0193US10927081B2Enhanced erythropoiesis and iron metabolismFIBROGEN INC·Filed 2018·Granted Feb 23, 2021·3 cites·46 claims
- 0293US7405274B2Connective tissue growth factor antibodiesFIBROGEN INC·Filed 2004·Granted Jul 29, 2008·47 cites·28 claims
- 0392US8466172B2Stabilization of hypoxia inducible factor (HIF) alphaGUENZLER-PUKALL VOLKMAR·Filed 2010·Granted Jun 18, 2013·18 cites·8 claims
- 0492US7871617B2Antibodies that bind to a portion of the VWC domain of connective tissue growth factorFIBROGEN INC·Filed 2008·Granted Jan 18, 2011·16 cites·45 claims
- 0591US8318703B2Methods for improving kidney functionKLAUS STEPHEN J·Filed 2006·Granted Nov 27, 2012·21 cites·10 claims
- 0689US11680047B2Enhanced erythropoiesis and iron metabolismFIBROGEN INC·Filed 2020·Granted Jun 20, 2023·1 cites·23 claims
- 0784US2024076364A1Connective tissue growth factor antibodiesFIBROGEN INC·Filed 2022·Application pending·0 cites
- 0879US2021369702A1Methods for treating anemia in subjects having kidney failure using inhibitors of hypoxia-inducible factor (hif) hydroxylaseFIBROGEN INC·Filed 2021·Application pending·0 cites
- 0975US9034643B2Connective tissue growth factor antibodiesFIBROGEN INC·Filed 2012·Granted May 19, 2015·1 cites·12 claims
- 1074US2021230259A1Connective tissue growth factor antibodiesFIBROGEN INC·Filed 2020·Application pending·0 cites
- 1167US2019023778A1Connective tissue growth factor antibodiesFIBROGEN INC·Filed 2018·Application pending·0 cites
- 1267US2015080425A1Methods for treating anemia in subjects having kidney failure using inhibitors of hypoxia-inducible factor (hif) hydroxylaseKLAUS STEPHEN J·Filed 2014·Application pending·0 cites
- 1365US2017312268A1Methods for treating a neurological disorder in a subject using inhibitors of hypoxia-inducible factor (hif) proyl hydroxylaseFIBROGEN INC·Filed 2017·Application pending·0 cites
- 1463US2013245037A1Stabilization of Hypoxia Inducible Factor (HIF) AlphaGUENZLER-PUKALL VOLKMAR·Filed 2013·Application pending·0 cites
- 1563US2013203805A1Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylaseKLAUS STEPHEN J·Filed 2012·Application pending·0 cites
- 1662US2006270699A1Stabilization of hypoxia inducible factor (HIF) alphaFIBROGEN INC·Filed 2006·Application pending·0 cites
- 1762US2006258660A1Stabilization of hypoxia inducible factor (HIF) alphaFIBROGEN INC·Filed 2006·Application pending·0 cites
- 1862US2006258702A1Stabilization of hypoxia inducible factor (HIF) alphaFIBROGEN INC·Filed 2006·Application pending·0 cites
- 1961US2006178317A1Methods of increasing endogenous erythropoietin (EPO)FIBROGEN INC·Filed 2006·Application pending·0 cites
- 2061US2006183695A1Methods of increasing endogenous erythropoietin (EPO)FIBROGEN INC·Filed 2006·Application pending·0 cites
- 2161US2006178316A1Methods of increasing endogenous erythropoietin (EPO)FIBROGEN INC·Filed 2006·Application pending·0 cites
- 2260US2011166178A1Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylaseFIBROGEN INC·Filed 2011·Application pending·0 cites
- 2360US2016257740A1Connective Tissue Growth Factor AntibodiesFIBROGEN INC·Filed 2016·Application pending·0 cites
- 2457US2011091468A1Connective tissue growth factor antibodiesFIBROGEN INC·Filed 2010·Application pending·0 cites
- 2557US2011039878A1Methods for reducing blood pressureGUENZLER-PUKALL VOLKMAR·Filed 2008·Application pending·0 cites
- 2657US2016024198A1Connective tissue growth factor antibodiesFIBROGEN INC·Filed 2015·Application pending·0 cites
- 2756US2014163061A1Methods For Reducing Blood PressureGUENZLER-PUKALL VOLKMAR·Filed 2014·Application pending·0 cites
- 2855US2003153503A1Methods of increasing endogenous erythropoietin (EPO)Filed 2002·Application pending·0 cites
- 2955US2003176317A1Stabilization of hypoxia inducible factor (HIF) alphaFiled 2002·Application pending·0 cites
- 3038US8314059B2Diabetic nephropathy therapiesFLYVBJERG ALLAN·Filed 2010·Granted Nov 20, 2012·0 cites·4 claims
- 3137US2005214294A1Diabetic nephropathy therapiesFLYVBJERG ALLAN·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →